Supreme Court Report

Supreme Court of the United States · Official docket →

Pfizer Inc., et al. v. Rite Aid Corporation, et al.

Paid petition · United States Court of Appeals for the Third Circuit, No. 14-4202, 14-4203, 14-4204, 14-4205, 14-4206, 14-4602 · judgment August 21, 2017

Certiorari denied · February 20, 2018
Pre-decision estimate: 11% cert probability (95% interval 7%–17%)

Before the decision, about 2.7× the 4.1% base rate. The model weighted this up for a Third Circuit decision below, a circuit split argued in the petition, and a dissent in the court below (flagged in the petition), and down for a business respondent.

Question presented

JOHN C. O’QUINN MICHAEL D. SHUMSKY JONATHAN D. JANOW ANDREW C. LAWRENCE KIRKLAND & ELLIS LLP 655 Fifteenth Street NW Washington, DC 20005 Counsel for Ranbaxy Inc., et al.

Counsel of record

For petitioner
Jay Philip Lefkowitz
Kirkland & Ellis LLP

For respondent
Bruce E. Gerstein
Garwin Gerstein & Fisher LLP

Case

Conference history
Distributed for 1 conference

Related
Vide, 17-771

Proceedings

  1. Feb 20 2018
    Motion for leave to file amicus brief filed by Washington Legal Foundation GRANTED.
  2. Feb 20 2018
    Motion for leave to file amici brief filed by Pharmaceutical Research and Manufacturers of America, et al. GRANTED.
  3. Feb 20 2018
    Petition DENIED.
  4. Jan 10 2018
    DISTRIBUTED for Conference of 2/16/2018.
  5. Dec 22 2017
    Motion for leave to file amicus brief filed by Washington Legal Foundation.
  6. Dec 22 2017
    Motion for leave to file amicus brief filed by Pharmaceutical Research and Manufacturers of America, et al.
  7. Dec 13 2017
    Waiver of right of respondents American Sales Company, Inc. and Professional Drug Company, Inc. to respond filed.
  8. Nov 20 2017
    Petition for a writ of certiorari filed. (Response due December 22, 2017)